| Literature DB >> 31569766 |
Zewen Chu1,2,3, Haibo Wang1,2,3, Tengyang Ni1,2,3, Li Tao1,2,3, Liangliang Xiang1,2,3, Zhen Zhou1,2,3, Yayun Qian1,2,3, Masataka Sunagawa4, Yanqing Liu5,6,7.
Abstract
Gastric cancer is the fifth most common tumor and has the third-highest mortality rate among various malignant tumors, and the survival rate of patients is low. Celastrus orbiculatus extract has been shown to inhibit the activity of a variety of tumors. This study explored the inhibitory effect of the oleanane-type triterpenoid acid 28-hydroxy-3-oxoolean-12-en-29-oic acid molecule from Celastrus orbiculatus extract on gastric cancer cell invasion and metastasis and determined its mechanism. 28-Hydroxy-3-oxoolean-12-en-29-oic acid was first diluted to various concentrations and then used to treat SGC-7901 and BGC-823 cells. Cell proliferation was assessed by an MTT (thiazole blue) assay. Transwell and wound healing assays were used to assess cell invasion and migration. High-content imaging technology was used to further observe the effects of the drug on cell invasion and migration. Western blotting was used to assess the effects on the expression of matrix metalloproteinases (MMPs) and the effects on epithelial-mesenchymal transition (EMT)-related proteins and phosphorylation-related proteins. We found that 28-Hydroxy-3-oxoolean-12-en-29-oic acid inhibited the migration and invasion of SGC-7901 and BGC-823 gastric cancer cells in a dose-dependent manner. Consequently, 28-hydroxy-3-oxoolean-12-en-29-oic acid decreased the expression of EMT-related proteins and MMPs in gastric cancer cells and reduced protein phosphorylation, inhibiting the migration and invasion of gastric cancer cells.Entities:
Keywords: Celastrus orbiculatus; EMT; MMP; invasion; migration
Mesh:
Substances:
Year: 2019 PMID: 31569766 PMCID: PMC6803947 DOI: 10.3390/molecules24193513
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.411
Figure 1The molecular structure of several oleanane-type triterpenoid acid extracted from the Celastrus orbiculatus Thunb. Their names and types, and their inhibition rate to gastric cancer cells are shown in the figure.
Figure 2(A) Growth inhibitory effects of 28-hydroxy-3-oxoolean-12-en-29-oic acid on SGC-7901. (B) Growth inhibitory effects of 28-hydroxy-3-oxoolean-12-en-29-oic acid on BGC-823. Cells were treated with various concentrations of 28-hydroxy-3-oxoolean-12-en-29-oic acid (10, 20, 40, 80 and 160 µmol/L) for 24 h, 48 h and 72 h, and cell viability was assessed by an MTT (thiazole blue) assay.
Figure 3(A) Cell invasion assays were conducted using 24-well Transwell chambers with 8.0-μm pore size polycarbonate membranes precoated with Matrigel. After treatment with various concentrations of 28-hydroxy-3-oxoolean-12-en-29-oic acid (40, 80 and 160 μmol/L) for 24 h, the invaded cells on the lower membrane surfaces were fixed and stained with 5% crystal violet solution. (B) Cell migration assays did not use Matrigel coating. Images of SGC-7901 and BGC-823 cells were acquired under a microscope at 200× magnification. (C,D) 28-Hydroxy-3-oxoolean-12-en-29-oic acid treatment for 24 h inhibited the migration of SGC-7901 cells and BGC-823 cells in a wound-healing assay in a dose-dependent manner. Images of SGC-7901 and BGC-823 cells were acquired under a microscope at 200× magnification.
Figure 4(A,D) After treatment with various concentrations of 28-hydroxy-3-oxoolean-12-en-29-oic acid (40, 80 and 160 μmol/L) for 24 h, the mean square displacement was plotted vs. the observation time from well-level data. A chemokinesis assay was performed with digital phase contrast (DPC) imaging using single-cell tracking. (B,E) After treatment with various concentrations of 28-hydroxy-3-oxoolean-12-en-29-oic acid (40, 80 and 160 μmol/L) for 12 h, SGC-7901 cells and BGC-823 cells were seeded and imaged with the 20× objective in the DPC channel. Cells were identified using the Find Cells module, and migration was monitored for 12 h using the Track Objects module. (C,F) Cell displacement was visualized. Current displacement Y was plotted against current displacement X using the Multiple Graphs module for display. Each point corresponds to the displacement of a cell at a given time point.
Figure 5(A,C) Changes in the expression levels of matrix metalloproteinases (MMPs) following treatment with 28-hydroxy-3-oxoolean-12-en-29-oic acid for 24 h were assessed by Western blotting. (B,D) The band intensities of TIMP-1,MMP-9 and MMP-2 relative to untreated control cells were quantified upon normalizing to β-actin expression, and are expressed as the mean ± standard deviation of three independent experiments.
Figure 6(A,C) Changes in epithelial–mesenchymal transition (EMT) biomarker expression levels following 28-hydroxy-3-oxoolean-12-en-29-oic acid for 24 h were assessed by Western blotting. (B,D) The band intensities of E-cadherin, N-cadherin and vimentin relative to untreated control cells were quantified upon normalizing to β-actin expression, and are expressed as the mean ± standard deviation of three independent experiments.
Figure 7(A,C) Changes in PI3K/AKt/Snail biomarker expression levels following treatment with 28-hydroxy-3-oxoolean-12-en-29-oic acid for 24 h were assessed by Western blotting. (B,D) The band intensities of AKt, (p)-Akt, PI3K, (p)-PI3K and Snail relative to untreated control cells were quantified upon normalizing to β-actin expression, and are expressed as the mean ± standard deviation of three independent experiments.